Net income increased 16.4%
Net income changed +16.4% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +16.4% from the comparable as-filed period.
Revenue changed +1.5% from the comparable as-filed period.
Cash & equivalents changed +9.1% from the comparable as-filed period.
Gross profit changed +8.0% from the comparable as-filed period.
SBC / revenue changed -5 basis points from the comparable as-filed period.
Research & development changed +1.7% from the comparable as-filed period.
Stock-based compensation changed -7.7% from the comparable as-filed period.
Selling, general & administrative changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.